Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 4 hours agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 7 hours agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share ( ...
Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Simply Wall St. via Yahoo Finance· 11 hours agoMerck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 10 hours agoMerck & Co (NYSE:MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
Merck On Track for Largest Percent Decrease Since October 2023 — Data Talk
Morningstar· 7 hours agoMerck & Co., Inc. (MRK) is currently at $126.30, down $3.19 or 2.46% --Would be lowest close since April 19, 2024, when it closed at $125.78 --On pace for ...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 3 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 11 hours agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 8 hours agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 6 days ago(NYSE:MRK), it is important to understand the ownership structure of the business. We can see that...
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 6 days agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a ...